Clinician's perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19.
Murat YıldızFunda AksuNurdan YıldızKurtuluş AksuPublished in: Revista da Associacao Medica Brasileira (1992) (2021)
Adherence to medication is not at the desired levels in patients with obstructive lung diseases. However, when faced with a serious health threat, such as the COVID-19 pandemic, patients realize the severity of their illness and begin using their treatments more regularly.
Keyphrases
- end stage renal disease
- healthcare
- coronavirus disease
- ejection fraction
- public health
- newly diagnosed
- chronic kidney disease
- sars cov
- prognostic factors
- mental health
- emergency department
- type diabetes
- metabolic syndrome
- patient reported outcomes
- health information
- climate change
- skeletal muscle
- human health
- patient reported